NEWS: 公告在東京證券交易所JASDAQ標準市場新上市


細胞培養蛋白質表面塗層的全球市場 - 成長、趨勢、預測

Cell Culture Protein Surface Coatings Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 707239
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
細胞培養蛋白質表面塗層的全球市場 - 成長、趨勢、預測 Cell Culture Protein Surface Coatings Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年08月01日內容資訊: 英文 114 Pages


第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 推動市場要素
  • 阻礙市場要素
  • 波特的五力分析

第5章 市場區隔

  • 蛋白質的各原料
    • 動物來源蛋白質
    • 人來源蛋白質
    • 合成蛋白質
    • 植物來源蛋白質
  • 塗層的各類型
    • 自塗層
    • 預塗層
      • 微孔盤
      • 淺底盤
      • 燒瓶
      • 幻燈片
      • 其他
  • 各地區
    • 北美 (美國,加拿大,墨西哥)
    • 歐洲 (法國,德國,英國,義大利,西班牙等)
    • 亞太地區 (中國,日本,印度,澳洲,韓國等)
    • 中東、非洲 (波灣合作理事會 (GCC) 各國,南非等)
    • 南美 (巴西,阿根廷等)

第6章 競爭環境

  • 企業簡介
    • Abcam PLC
    • Corning Incorporated
    • Greiner Bio-One International AG
    • Merck KGaA (Merck Millipore)
    • Promega Corporation
    • Qiagen N.V.
    • Sartorius Stedim Biotech SA
    • Thermo Fisher Scientific Inc.
    • Viogene BioTek Corporation

第7章 市場機會及未來趨勢


Product Code: 64026

The cell culture protein surface coatings market is expected to register a CAGR of nearly 9.5%, during the forecast period. The optimization of cell culture environment enables cells to grow, function, and survive in a realistic and representative manner. The surface coating of cell culture with protein involves coating the cell culture surface with extracellular matrix or protein components, in order to improve the proliferation and adhesion of the cells in-vitro. Corning is among the oldest companies advanced in the cell-culture surface technology, with a long legacy of developing new surfaces with expanded capabilities.

Some of the major drivers for this market include increasing research related to stem cells. Recent years have witnessed the high importance of stem cells in treating many chronic diseases, and it has been observed that stem cells have great potential for cell therapy, protein cell culture, tissue engineering, and regenerative medicine. The other drivers include growing demand for protein therapeutics and targeted therapy, as well as a steady increase in the preference toward 3D cell cultures over 2D cell cultures. However, there are several government laws and individual societies' norms, which inhibit the use of animal-sourced protein coating. This restricts the growth of the overall market, along with the high cost associated with cell culture protein.

Key Market Trends

Synthetic Proteins are Expected to Provide Fast Growth for the Market over the Forecast Period

Consequently, artificial proteins are the leading category of protein sources in the cell culture protein surface coatings market. The synthetic proteins have a relatively lower risk proposition, as they are less prone to contamination. There is a wide range of applications observed by scientific researchers in their studies, such as the potential early treatment of diseases like cancer and diabetes. There is a growing application related to protein therapeutics and technological advancement. Moreover, it is an alternative origin of animal source, which drives its importance in research communities and markets. Thus, it is estimated to grow the fastest, over the forecast period.

North America is Estimated to Hold the Largest Share in the Market

North America is well known for its cell culture laboratories and funding for research in the healthcare domain. Every year, in the United States, the National Institutes of Health (NIH) heavily funds stem cell research. For research in cancer diseases and personalized medicine, the National Cancer Institute (NCI) allocates high funds to universities and companies collaborating with research centers. Such factors boost the importance of cell culture activities. The healthcare expenditure is, therefore, high in the United States and Canada.

Competitive Landscape

The major market players are focusing on technological advancements in protein technology and cell culture techniques. Some of the major players in the market are Corning Incorporated, Greiner Bio-One International AG, Merck Millipore, Qiagen NV, and Thermo Fisher Scientific Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Inceasing Stem Cell Research Activities
    • 4.2.2 Increasing Demand of Protein Therapeutics and Targeted Therapy
    • 4.2.3 Growing Preference for 3D Cell Cultures over 2D Cell Cultures
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Cell Culture Protein Surface Coatings Products
    • 4.3.2 Restriction Against Use of Animal Source Protein Coating Material
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Protein Source
    • 5.1.1 Animal-derived Protein
    • 5.1.2 Human-derived Protein
    • 5.1.3 Synthetic Protein
    • 5.1.4 Plant-derived Protein
  • 5.2 By Type of Coating
    • 5.2.1 Self-coating
    • 5.2.2 Pre-coatings
      • Microwell Plates
      • Petri Dish
      • Flask
      • Slides
      • Other Types of Pre-coatings
  • 5.3 By Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • France
      • Germany
      • United Kingsom
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • GCC
      • South Africa
      • Rest of Middle-East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Abcam PLC
    • 6.1.2 Corning Incorporated
    • 6.1.3 Greiner Bio-One International AG
    • 6.1.4 Meark KGaA (Merck Millipore)
    • 6.1.5 Promega Corporation
    • 6.1.6 Qiagen NV
    • 6.1.7 Sartorius Stedim Biotech SA
    • 6.1.8 Thermo Fisher Scientific Inc.
    • 6.1.9 Viogene BioTek Corporation